Assessing the Impact of Old Age on Upper Tract Urothelial Carcinoma: A Retrospective Analysis from a Portuguese Tertiary Center

Authors

  • Frederico Portugal Gaspar Serviço de Urologia, Hospital Egas Moniz – Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal https://orcid.org/0000-0002-6267-0451
  • Filipe Lopes Serviço de Urologia, Hospital Egas Moniz – Unidade Local de Saúde Lisboa Ocidental, Lisboa, Portugal
  • Jorge Correia Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • João Carvalho Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • Rui Freitas Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • Isaac Braga Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • José Sanches Magalhães Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • Vítor Silva Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • Francisco Lobo Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal
  • António Morais Serviço de Urologia Instituto Português de Oncologia Francisco Gentil do Porto, Porto, Portugal

DOI:

https://doi.org/10.24915/aup.250

Keywords:

Aged, Carcinoma, Transitional Cell, Nephroureterectomy, Neoplasm Recurrence, Local, Ureteral Neoplasms, Urinary Bladder Neoplasms

Abstract

Introduction: Upper tract urothelial carcinoma is an infrequent but aggressive disease. Radical nephroureterectomy is the standard of care for nonmetastatic tumors. The potential implications of old age in the management of upper tract urothelial carcinoma are still controversial. Our aim was to analyze the effect of old age on peri-operative and oncological outcomes after radical nephroureterectomy.

Methods: We performed an observational and retrospective analysis of patients submitted to radical nephroureterectomy for nonmetastatic upper tract urothelial carcinoma in our centre between January 2018 and June 2023. Seventy-nine patients were included and divided according to their age at the time of surgery (<80 or ≥80 years old). Perioperative variables and oncological outcomes were compared between the groups. Kaplan–Meier analysis and univariable Cox regression models were used to evaluate disease-free survival, metastasis-free survival and overall survival distribution between the groups.

Results: Sixteen patients (20.5%) were aged 80 or older. We found an association between older age and a higher proportion of invasive disease (pT2 or higher; p=0.048). We also observed that omission of bladder cuff excision was more common in older patients (p=0.008). We found no differences regarding perioperative outcomes. Also, no differences in oncological outcomes, namely, disease-free survival (p=0.884), metastasis-free survival (p=0.867) and overall survival (p=0.916) were found.

Conclusion: Older age at the time of radical nephroureterectomy had no detrimental effect on perioperative and oncological outcomes. Our results suggest that older age by itself should not preclude radical nephroureterectomy.

Downloads

Download data is not yet available.

References

Sofia F, Shariat SF, Lemer SP, Fritsche HM, Rink M, Kassout W, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35:379-87. doi:10.1007/s00345-016-1928-x

Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer. 2009;115:1224-33. doi:10.1002/cncr.24135

Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer. 2009;45:3291-7. doi:10.1016/j.ejca.2009.06.016

Roupréi M, Seisen T, Brite AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol. 2023;84:49-64. doi:10.1016/j.eururo.2023.03.013

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63. doi:10.3322/caac.21834

Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassout W, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29:481-6. doi:10.1007/s00345-010-0594-7

Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz Pl, Raman JD, et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010;105:1672-7. doi:10.1111/j.1464-410X.2009.09072.x

Chromecki TF, Endaie B, Novara G, Pummer K, Zigeuner R, Seitz C, et al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol. 2011;29:473-80. doi:10.1007/s00345-011-0677-0

Ferro M, Chiigica S, Vartolomei MD, Bove P, Porreca A, Busetto GM, et al. Advanced age impacts survival after radical nephroureterectomy for upper tract urothelial carcinoma. Clin Genitourin Cancer. 2024;22:27-37. doi:10.1016/j.clgc.2023.08.001

Ye J, Wu Q, Liao X, Zheng L, Wei Q, Bao Y. Advanced Age may not be an absolute contraindication for radical nephroureterectomy in patients with upper tract urothelial carcinoma: a single-center case series and a systematic review with meta-analyses. J Clin Med. 24 2023;12. doi:10.3390/jcm12237273

Yamada Y, Ikeda M, Hirayama T, Murakami Y, Koguchi D, Matsuda D, et al. Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma. Asia Pac J Clin Oncol. 2023;19:305-11. doi:10.1111/ajco.13835

Koteraazwa S, Kanno T, Kobori G, Ito K, Nakagawa H, Takahashi T, et al. Clinical outcomes following laparoscopic radical nephroureterectomy in octogenarians. Int J Clin Oncol. 2023;28:155-62. doi:10.1007/s10147-022-02269-8

Ishikawa M, Muramoto K, Yoshihara K, Yamamoto S, Miyajima K, Iwatani K, et al. Does age impact clinical outcomes of radical nephroureterectomy in the elderly? results from a multicenter retrospective study. Transl Androl Urol. 2024;1:688-98. doi:10.21037/tau-24-37

World Health Organization 2025 data.who.int, Portugal. [accessed on 11 February 2025] Available at: https://data.who.int/countries/620.

Amin MB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 8th ed. Chicado: Springer; 2017.

Netto GJ, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82. doi:10.1016/j.eururo.2022.07.002

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13. doi:10.1097/01.sla.0000133083.54334.ae

Teoh JY, Ng CF, Eto M, Chiruvella M, Capitanio U, Esen T, et al. Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities. World J Urol. 2022;40:2657-65. doi:10.1007/s00345-022-04152-7

Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014;65:210-7. doi:10.1016/j.eururo.2012.04.052

Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK,et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014;65:650-8. doi:10.1016/j.eururo.2013.09.003

Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R,et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67:1122-33. doi:10.1016/j.eururo.2014.11.035

Yong C, Slaven JE, Wu Z, Margulis V, Djaladat H, Antonelli A, et al. The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry. Urol Oncol. 2024;42:373.e1-373.e7. doi:10.1016/j.urolonc.2024.06.001

Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L, et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol. 2010;57:956-62. doi:10.1016/j.eururo.2009.12.001

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Soulières D, et al. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis. Eur Urol Focus. 2020;6:298-304. doi:10.1016/j.euf.2018.09.007

Zlotta AR. Should urologists always perform a bladder cuff resection during nephroureterectomy, and which method should they use? Eur Urol. 2010;57:970-2. doi:10.1016/j.eururo.2010.01.043

Published

2025-07-28

Issue

Section

Original Article